Vaccine-induced immune responses are as durable in people living with HIV as in people without HIV
A CITF-funded study published in AIDS, from Mark Brockman and Zabrina Brumme (Simon Fraser University and BC Centre for Excellence in HIV/AIDS), along with Drs. Aslam Anis and Marc Romney (University of British Columbia) showed that the antibody responses induced by a third dose of COVID-19 vaccine were as durable in people living with HIV (PLWH) receiving antiretroviral therapy (ART) as in individuals without HIV.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed